UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 7, 2006
NUTRACEUTICAL INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | | 000-23731 | | 87-0515089 |
(State of incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
| | | | |
1400 Kearns Boulevard, 2nd Floor
Park City, Utah | | 84060 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (435) 655-6106
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On September 7, 2006, Nutraceutical International Corporation announced that it had amended its January 2002 revolving credit facility.
Item 9.01 Financial Statements and Exhibits.
Exhibits.
10.8 First Amendment to Credit Agreement dated as of September 7, 2006 among Nutraceutical and its lenders
99.1 Press release issued by Nutraceutical dated September 7, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NUTRACEUTICAL INTERNATIONAL CORPORATION | |
| (Registrant) | |
| | |
| | |
| By: | /S/ LESLIE M. BROWN, JR. | |
Date: September 7, 2006 | | Leslie M. Brown, Jr. | |
| | Senior Vice President, Finance, Chief Financial Officer and | |
| | Assistant Secretary | |
| | (Principal Financial and Accounting Officer) | |
2
EXHIBIT INDEX
Exhibit Number | | Description |
| | |
10.8 | | First Amendment to Credit Agreement dated as of September 7, 2006 among Nutraceutical and its lenders |
| | |
99.1 | | Press release issued by Nutraceutical dated September 7, 2006 |
3
